Multiple Sclerosis News Today

FDA approves generic injection to help manage MS

The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.
Pharmabiz

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis

ScinoPharm receives US FDA approval for glatiramer acetate injection to treat multiple sclerosis: Taiwan Tuesday, January 6, 2026, 14:00 Hrs [IST] ScinoPharm Taiwan, a professiona ...
The Malaysian Reserve

ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis

Since its approval in 1996, Glatiramer Acetate (GA) has been recognized as one of the most challenging complex synthetic polypeptides globally. To address the unique nature of such products, the U.S.

ScinoPharm Taiwan Ltd.: ScinoPharm Secures U.S. FDA Approval for Glatiramer Acetate Injection for the Treatment of Multiple Sclerosis

ScinoPharm Taiwan (TWSE: 1789) today announced a landmark achievement in the global pharmaceutical landscape, securing U.S. Food ...
The Pharma Letter

ScinoPharm wins US approval for complex MS generic

Taiwanese drugmaker ScinoPharm (TWSE: 1789) has secured approval from the US Food and Drug Administration for its glatiramer ...
BioWorld

Zenas plummets on solid phase III data in IgG4-RD; BLA planned

Shares of Zenas Biopharma Inc. (NASDAQ:ZBIO) were trading at $15.04, down $19.46, or 56%, on positive results from the phase III Indigo trial with obexelimab in immunoglobulin G4-related disease (IgG4 ...